Trial
NCT01550185
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
GlaxoSmithKline
Condition
Adult Acute Basophilic Leukemia
Intervention
eltrombopag olamine
Why stopped
Sponsor wanted study rewritten
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-22